Growth Metrics

Palvella Therapeutics, Inc. (PVLA) Preferred Shares (2016 - 2017)

Palvella Therapeutics (PVLA) has disclosed Preferred Shares for 2 consecutive years, with $5.0 as the latest value for Q3 2017.